Looking for a way to enhance your compounding pharmacy or facility's capabilities, keep your team up-to-date on industry developments, and connect with fellow compounding professionals?
APC this week asked FDA’s Center for Veterinary Medicine to provide additional guidance on compliance with its GFI 256 on animal drug compounding.
APC this week wrote to the Tennessee Board of Pharmacy to express concern that the board has not shown evidence that two proposed compounding-related regulations will improve patient safety.
APC this week submitted a comment letter expressing concern over the California Board of Pharmacy's proposed changes to regulations related to sterile compounding.
This week APC sent a comment letter to the Montana Senate Business, Labor, and Economic Affairs Committee considering HB 152, which recently passed the Montana house.
The recent withdrawal of Makena by the FDA has created complications for pharmacy compounders, particularly regarding the use of hydroxyprogesterone.
The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly scientific and professional journal for conscientious compounding pharmacists.
Small Business Rising is a grassroots organization advocating for policies that support small businesses. Compounding pharmacy owners can join their mailing list to stay informed about relevant legislation and advocacy efforts.
In a letter sent this week to FDA’s Center for Veterinary Medicine, APC corrected misleading input provided to the agency in a February comment letter from the Animal Health Institute and Generic Animal Drug Alliance.
We’re calling for nominations for the 2023 APC Fellows Program. This program recognizes the distinguished contributions made by compounding pharmacist and pharmacy technician members to the profession and their communities.
FOLLOW US
